Loading...
SCL logo

Stepan CompanyInforme acción NYSE:SCL

Capitalización bursátil US$1.2b
Precio de las acciones
US$52.85
US$75
29.5% infravalorado descuento intrínseco
1Y-2.7%
7D1.5%
1D
Valor de la cartera
Ver

Stepan Company

Informe acción NYSE:SCL

Capitalización de mercado: US$1.2b

Stepan (SCL) Resumen de Acciones

Stepan Company, junto con sus filiales, produce y vende especialidades químicas y productos químicos intermedios a otros fabricantes para su uso en diversos productos finales en Estados Unidos, Francia, Polonia, Reino Unido, Brasil, México y a escala internacional. Saber más

Análisis fundamental de SCL
Puntuación del snowflake
Valoración5/6
Crecimiento futuro3/6
Rendimiento pasado0/6
Salud financiera3/6
Dividendos3/6

SCL Community Fair Values

Create Narrative

See what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.

Competidores de Stepan Company

Historial de precios y rendimiento

Resumen de las cotizaciones máximas, mínimas y variaciones del Stepan
Precios históricos de las acciones
Precio actual de la acciónUS$52.85
Máximo en las últimas 52 semanasUS$68.00
Mínimo de 52 semanasUS$41.82
Beta0.95
Cambio en 1 mes2.44%
Variación en 3 meses4.63%
Cambio de 1 año-2.65%
Variación en 3 años-46.03%
Variación en 5 años-60.60%
Variación desde la OPV9,739.72%

Noticias y actualizaciones recientes

Recent updates

Actualización de narrativa Apr 28

SCL: Stable Margins And Buybacks Will Support Long-Term Dividend Upside

Analysts kept their fair value estimate steady at $75, with only marginal tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions. This indicates a largely unchanged view of Stepan's longer term potential.
Actualización de narrativa Apr 12

SCL: Stable Margins And Buyback Completion Will Support Long-Term Dividend Upside

Analysts have nudged their Stepan price target slightly higher to $75.00, with modest tweaks to the discount rate and P/E assumptions supporting this updated view. What's in the News For the three months ended December 31, 2025, Stepan Company reported unaudited goodwill impairment of $6,245,000, which directly affects reported earnings quality for that period (Key Developments).
Seeking Alpha Mar 28

Stepan Company: The Ride Higher Isn't Over Yet

Summary Stepan Company (SCL) is reaffirmed as a 'buy' due to compelling valuation and significant cost-saving initiatives. SCL's Project Catalyst targets $100M in pre-tax savings over two years, with 60% expected in the current year. Despite mixed profitability and cash flow, SCL remains attractively priced versus peers, especially on cash flow metrics. Even if cost savings underdeliver, current valuation provides downside protection and long-term upside potential. Read the full article on Seeking Alpha
Actualización de narrativa Mar 28

SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside

Analysts have maintained their Stepan fair value estimate at $75.00, making only small adjustments to the discount rate, revenue growth, profit margin and future P/E assumptions. This signals that their overall view on the stock’s longer-term potential remains largely unchanged.
Actualización de narrativa Mar 14

SCL: Steady Fair Value And Margins Will Support Long-Term Dividend Upside

Analysts have modestly revised their price outlook for Stepan, keeping fair value around $75.00 while making small tweaks to the discount rate and projected P/E. This reflects updated assumptions about the risk profile and valuation multiples rather than a shift in the underlying growth or margin view.
Actualización de narrativa Feb 27

SCL: Higher Future P/E Assumptions Will Support Long-Term Dividend Upside

Analysts have adjusted their Stepan price target to $75.00, with the change tied to updated views on discount rate, revenue growth, profit margin, and a higher assumed future P/E multiple. What's in the News Stepan Company reported an unaudited goodwill impairment of $6,245,000 for the three months ended December 31, 2025.
Actualización de narrativa Feb 11

SCL: Refined Discount Rate Assumptions Will Support Long-Term Dividend Upside

Analysts have kept their Stepan price target steady at $75.00, citing only slight tweaks to assumptions like discount rate, revenue growth, profit margin, and future P/E that were not material enough to change their overall valuation view. Valuation Changes Fair Value: Steady at $75.00, indicating no change in the analysts' central valuation estimate.
Artículo de análisis Feb 04

Why Investors Shouldn't Be Surprised By Stepan Company's (NYSE:SCL) 26% Share Price Surge

Despite an already strong run, Stepan Company ( NYSE:SCL ) shares have been powering on, with a gain of 26% in the last...
Actualización de narrativa Jan 27

SCL: Higher Discount Rate Will Set Up Attractive Long-Term Dividend Returns

Analysts now estimate Stepan's fair value at US$75.00, reduced from US$82.21. This change reflects updated assumptions regarding a higher discount rate, revised profit margin expectations, a slightly higher revenue growth outlook, and a lower future P/E multiple.
Artículo de análisis Jan 08

Stepan (NYSE:SCL) May Have Issues Allocating Its Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
Artículo de análisis Dec 12

Why Stepan Company (NYSE:SCL) Could Be Worth Watching

Stepan Company ( NYSE:SCL ), is not the largest company out there, but it saw a double-digit share price rise of over...
Artículo de análisis Nov 04

Stepan (NYSE:SCL) Will Pay A Larger Dividend Than Last Year At $0.395

Stepan Company's ( NYSE:SCL ) periodic dividend will be increasing on the 15th of December to $0.395, with investors...
Artículo de análisis Sep 04

Here's What's Concerning About Stepan's (NYSE:SCL) Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Artículo de análisis Jul 31

Is It Time To Consider Buying Stepan Company (NYSE:SCL)?

While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...
Artículo de análisis Jun 10

Earnings Tell The Story For Stepan Company (NYSE:SCL)

Stepan Company's ( NYSE:SCL ) price-to-earnings (or "P/E") ratio of 22.5x might make it look like a sell right now...
Artículo de análisis May 02

Results: Stepan Company Exceeded Expectations And The Consensus Has Updated Its Estimates

A week ago, Stepan Company ( NYSE:SCL ) came out with a strong set of first-quarter numbers that could potentially lead...
Seeking Alpha Apr 20

Stepan Company's Plunge Offers Investors A Chance To Clean Up

Summary Markets are inefficient short-term, creating opportunities for logical, value-oriented investors; Stepan Company is now a ‘buy’ due to recent price drops and management's positive outlook. Despite a 6% revenue drop in 2024, Stepan Company improved net income and EBITDA, driven by cost-cutting measures and productivity improvements. Management is optimistic about 2025, expecting volume growth, margin improvement, and positive free cash flow, targeting high-margin, growth-oriented markets. Analysts forecast revenue and earnings growth for Q1 2025; shares are attractively priced compared to peers, justifying an upgrade to a ‘buy’ rating. Read the full article on Seeking Alpha
Artículo de análisis Apr 16

Should You Investigate Stepan Company (NYSE:SCL) At US$47.60?

While Stepan Company ( NYSE:SCL ) might not have the largest market cap around , it received a lot of attention from a...
Seeking Alpha Feb 04

Stepan Company: A 'Moderate Buy' Despite A High Valuation

Summary Stepan Company, a specialty chemicals manufacturer, excels in operational efficiency and dividend growth, making it a stable investment despite current valuations. Q3 FY24 financials show margin expansion and significant net income growth, despite a 3% revenue decline, highlighting fiscal discipline. Trading at a forward P/E of 17.3x for 2025, Stepan's stock has a potential 26% upside, making it a promising investment opportunity. I am an investment analyst with a focus on income generation. Read the full article on Seeking Alpha
Artículo de análisis Jan 18

Shareholders Should Be Pleased With Stepan Company's (NYSE:SCL) Price

With a price-to-earnings (or "P/E") ratio of 31.4x Stepan Company ( NYSE:SCL ) may be sending very bearish signals at...
Artículo de análisis Nov 26

These 4 Measures Indicate That Stepan (NYSE:SCL) Is Using Debt Extensively

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Artículo de análisis Nov 02

Stepan's (NYSE:SCL) Upcoming Dividend Will Be Larger Than Last Year's

The board of Stepan Company ( NYSE:SCL ) has announced that the dividend on 13th of December will be increased to...
Seeking Alpha Oct 30

Stepan Company: Not A Great Performance, But Good Value

Summary Stepan Company, despite underperformance and volatility, has long-term upside due to its unique position in the specialty chemicals market, particularly surfactants. The company's fundamentals have improved with reduced CapEx and positive FCF, but current earnings and macro pressures persist. SCL's growth potential is tied to the surfactant segment and market diversification, though the timing of earnings recovery remains uncertain. I rate Stepan as a "Buy" with a $90 PT, but caution that there are superior investments in the chemicals sector with better returns. Read the full article on Seeking Alpha
User avatar
Nueva narrativa Sep 24

Calculated Supply Chain And Market Expansion Drive Robust Growth And Margin Improvement

Operational cost reductions and workforce productivity improvements aim to positively impact net margins.
Artículo de análisis Aug 30

Some Investors May Be Worried About Stepan's (NYSE:SCL) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
Artículo de análisis Aug 17

Stepan (NYSE:SCL) Takes On Some Risk With Its Use Of Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Seeking Alpha Jul 28

Stepan Company Is Making Great Progress

Summary Stepan Company faced declining revenue, profits, and cash flows due to weak demand and inventory destocking, leading to a 'hold' rating. Despite a difficult 2023, the company showed improvements in cash flows and margins in the first quarter of 2024. Analysts expect revenue and earnings per share to improve in the second quarter of 2024, but shares are not yet attractively priced for an upgrade. Read the full article on Seeking Alpha

Rentabilidad de los accionistas

SCLUS ChemicalsMercado US
7D1.5%-1.1%1.5%
1Y-2.7%6.3%28.6%

Rentabilidad vs. Industria: Los resultados de SCL fueron inferiores a los de la industria US Chemicals, que obtuvo un rendimiento del 6.3% el año pasado.

Rentabilidad vs. Mercado: SCL obtuvo unos resultados inferiores a los del mercado US, que fueron del 28.6% el año pasado.

Volatilidad de los precios

Is SCL's price volatile compared to industry and market?
SCL volatility
SCL Average Weekly Movement4.3%
Chemicals Industry Average Movement7.4%
Market Average Movement7.2%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Precio estable de las acciones: SCL no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.

Volatilidad a lo largo del tiempo: La volatilidad semanal de SCL (4%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
19322,328Luis Rojowww.stepan.com

Stepan Company, junto con sus filiales, produce y vende especialidades químicas y productos químicos intermedios a otros fabricantes para su uso en diversos productos finales en Estados Unidos, Francia, Polonia, Reino Unido, Brasil, México y a escala internacional. Opera a través de tres segmentos: Surfactantes, Polímeros y Productos Especiales. El segmento de tensioactivos ofrece tensioactivos que se utilizan en productos de limpieza y desinfección de consumo e industriales, incluidos detergentes para lavar ropa, vajilla, alfombras y suelos y paredes, así como champús y jabones corporales; y otras aplicaciones, como suavizantes, compuestos cuaternarios germicidas, desinfectantes, ingredientes lubricantes; emulsionantes para extender productos agrícolas; y aplicaciones industriales que comprenden sistemas de látex, plásticos y compuestos.

Resumen de fundamentos de Stepan Company

¿Cómo se comparan los beneficios e ingresos de Stepan con su capitalización de mercado?
Estadísticas fundamentales de SCL
Capitalización bursátilUS$1.20b
Beneficios(TTM)-US$14.22m
Ingresos (TTM)US$2.34b
0.5x
Ratio precio-ventas (PS)
-84.4x
Ratio precio-beneficio (PE)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de SCL
IngresosUS$2.34b
Coste de los ingresosUS$2.08b
Beneficio brutoUS$259.28m
Otros gastosUS$273.50m
Beneficios-US$14.22m

Últimos beneficios comunicados

Mar 31, 2026

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)-0.63
Margen bruto11.06%
Margen de beneficio neto-0.61%
Ratio deuda/patrimonio54.6%

¿Cómo se ha desempeñado SCL a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

3.0%
Rentabilidad actual por dividendo
-251%
Ratio de pagos
¿Cuándo hay que comprar SCL para recibir un próximo dividendo?
fechas de dividendos de Stepan
Fecha ex dividendoJun 01 2026
Fecha de pago de dividendosJun 15 2026
Días hasta ex dividendo1 day
Días hasta la fecha de pago de dividendos15 days

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/31 01:35
Precio de las acciones al final del día2026/05/29 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Stepan Company está cubierta por 4 analistas. 2 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Michael HarrisonSeaport Research Partners
Daniel RizzoSidoti & Company, LLC
Vincent AndersonStifel, Equities Research